NPB-01

( DrugBank: - / KEGG DRUG: - )

3 diseases

ID	Disease name (Link within this page)	Number of trials
13	Multiple sclerosis/Neuromyelitis optica	1
14	Chronic inflammatory demyelinating polyneuropathy	2

ID	Disease name (Link within this page)	Number of trials
162	Pemphigoid	2

13. Multiple sclerosis/Neuromyelitis optica

Clinical trials : 3,340 / Drugs : 2,163 - (DrugBank : 383) / Drug target genes : 241 - Drug target pathways : 238

trials per page:

Showing 1 to 1 of 1 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01845584 (ClinicalTrials.gov)	May 2013	26/4/2013	Phase II Clinical Trial of NPB-01in Patients With Anti-aquaporin 4 Antibody Positive Neuromyelitis O ...	NPB-01(Intravenous Immunoglobulin) Therapy for Patients With Anti-aquaporin 4 Antibody Positive Neur ...	Neuromyelitis Optica Spectrum Disorder	Drug: NPB-01	Nihon Pharmaceutical Co., Ltd	NULL	Completed	20 Years	N/A	All	7	Phase 2	Japan

Clinical trials : 175 / Drugs : 161 - (DrugBank : 41) / Drug target genes : 13 - Drug target pathways : 24

trials per page:

Showing 1 to 2 of 2 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01824251 (ClinicalTrials.gov)	April 2013	1/4/2013	Phase III Clinical Trial of NPB-01maintenance Therapy in Patients With Chronic Inflammatory Demyelin ...	NPB-01(Intravenous Immunoglobulin) Maintenance Therapy for Patients With Chronic Inflammatory Demyel ...	Chronic Inflammatory Demyelinating Polyneuropathy	Drug: NPB-01	Nihon Pharmaceutical Co., Ltd	NULL	Completed	20 Years	100 Years	Both	49	Phase 3	Japan
2	NCT01827072 (ClinicalTrials.gov)	April 2013	1/4/2013	Phase III Clinical Trial of NPB-01maintenance Therapy in Patients With Multifocal Motor Neuropathy.	NPB-01(Intravenous Immunoglobulin) Maintenance Therapy for Patients With Multifocal Motor Neuropathy ...	Multifocal Motor Neuropathy	Drug: NPB-01	Nihon Pharmaceutical Co., Ltd	NULL	Completed	20 Years	100 Years	Both	13	Phase 3	Japan

Clinical trials : 90 / Drugs : 122 - (DrugBank : 47) / Drug target genes : 34 - Drug target pathways : 144

trials per page:

Showing 1 to 2 of 2 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01408550 (ClinicalTrials.gov)	August 2011	27/7/2011	Phase III Clinical Trial of NPB-01in Patients With Bullous Pemphigoid Unresponsive to Corticosteroid ...	NPB-01(Intravenous Immunoglobulin) Therapy for Patients With Bullous Pemphigoid Unresponsive to Cort ...	Bullous Pemphigoid	Drug: NPB-01;Drug: Placebo	Nihon Pharmaceutical Co., Ltd	NULL	Completed	20 Years	N/A	Both	56	Phase 3	Japan
2	NCT00809822 (ClinicalTrials.gov)	November 2008	11/12/2008	Clinical Trial of NPB-01 in Patients With Bullous Pemphigoid Unresponsive to Corticosteroids.	NPB-01(Intravenous Immunoglobulin) Therapy for Patients With Bullous Pemphigoid Unresponsive to Cort ...	Bullous Pemphigoid	Drug: NPB-01;Drug: Placebo	Nihon Pharmaceutical Co., Ltd	NULL	Completed	20 Years	N/A	Both	20	Phase 2	Japan